Search Tag: Hologic
Hologic Announces FDA Clearance of Aptima® Assay to Detect Herpes Simplex Virus 1 & 2
2017 21 Jun
Hologic, Inc. (Nasdaq: HOLX) has announced that it has obtained FDA clearance to market the Aptima® Herpes Simplex Virus (HSV) 1 & 2 molecular assay on the fully automated Panther® system. The test will be commercially available in the 50 United States, U.S. territories and Puerto Rico. According to the U.S. Centers for Disease Control and Prevention,... Read more
Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure®
2017 16 Jun
SculpSure Now Cleared to Treat Five Areas of the BodyHologic, Inc. (Nasdaq: HOLX) has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for Cynosure's non-invasive body contouring product, SculpSure, to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of... Read more
FDA Approves Hologic's Genius™ 3D Mammography™ Exam
2017 08 Jun
--Genius exam improves cancer detection and reduces recall rates for women of all ages and breast types, including the nearly 50 percent of women of breast cancer screening age who have dense breasts----Separate, recently published data analysis strongly supports starting breast cancer screening using tomosynthesis beginning at age 40--Hologic, Inc.... Read more
Charles J. Dockendorff Elected to Hologic Board of Directors
2017 17 May
Hologic, Inc. (Nasdaq: HOLX) has announced that Charles J. Dockendorff has been elected to the Company's Board of Directors, effective immediately. Mr. Dockendorff also was appointed to the Company's Audit and Finance Committee.Mr. Dockendorff, who has more than 25 years of experience in the global healthcare industry, was formerly the Executive Vice... Read more
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2017 on May 10, 2017
2017 04 Apr
Hologic, Inc. (Nasdaq: HOLX) has announced that the Company plans to release its financial results for the second quarter of fiscal 2017 on Wednesday, May 10, 2017, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.Interested participants may listen to the call by dialing... Read more
Hologic Completes Acquisition of Cynosure
2017 22 Mar
- Transaction Provides Entry into Large, Fast-Growing Medical Aesthetics Market, Boosts Hologic's Growth Rate -Hologic, Inc. (Nasdaq: HOLX) has announced that it has completed the acquisition of Cynosure, Inc., a leader in medical aesthetics systems and technologies, for $66 per share in cash."We are pleased to complete our acquisition of Cynosure,... Read more
FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay
2017 18 Feb
HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther systemHologic, Inc. (Nasdaq: HOLX) has announced that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of HCV viral load and confirming active HCV... Read more
Hologic to Acquire Cynosure,in All-Cash Tender Offer that Combines Two Complementary Businesses
2017 14 Feb
-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate -Accelerates Hologic's Top- and Bottom-Line Growth Rates and is Immediately Accretive to Non-GAAP Earnings per Share \Hologic, Inc. (Nasdaq: HOLX), a leader in women's health, and Cynosure, Inc. (Nasdaq: CYNO), a leader in... Read more
Hologic to Webcast Presentations at Upcoming Investor Conferences
2017 13 Feb
Hologic, Inc. (Nasdaq: HOLX) has announced that the Company will present at these upcoming investor conferences:The LEERINK Partners 6th Annual Global Healthcare Conference in New York, NY on Wednesday, February 15 at 3:30 pm Eastern Time (ET).The Raymond James 38th Annual Institutional Investor Conference in Orlando, FL on Monday, March 6 at& Read more
Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System
2017 03 Feb
--Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use--Hologic, Inc. (Nasdaq: HOLX) has announced the launch of its next-generation NovaSure® ADVANCED global endometrial ablation (GEA) system in the United States. The system has been FDA approved.The NovaSure system is designed to reduce... Read more
